- Home
- DIN vs MNPR Comparison
DIN vs MNPR Comparison
Compare DIN & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DIN | MNPR |
|---|---|---|
| Founded | 1958 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.8M | 368.9M |
| IPO Year | 1994 | 2019 |
Fundamental Metrics
Financial Performance| Metric | DIN | MNPR |
|---|---|---|
| Price | $27.86 | $53.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | $29.00 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 291.3K | 158.1K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.78% | N/A |
| EPS Growth | N/A | ★ 54.99 |
| EPS | ★ 1.11 | N/A |
| Revenue | ★ $879,300,000.00 | N/A |
| Revenue This Year | $3.61 | N/A |
| Revenue Next Year | $0.64 | N/A |
| P/E Ratio | $25.18 | ★ N/A |
| Revenue Growth | ★ 8.25 | N/A |
| 52 Week Low | $19.52 | $28.40 |
| 52 Week High | $39.68 | $105.00 |
Technical Indicators
Market Signals| Indicator | DIN | MNPR |
|---|---|---|
| Relative Strength Index (RSI) | 49.84 | 43.11 |
| Support Level | $27.52 | $50.77 |
| Resistance Level | $28.90 | $60.67 |
| Average True Range (ATR) | 1.18 | 2.92 |
| MACD | 0.10 | -0.31 |
| Stochastic Oscillator | 60.22 | 24.08 |
Price Performance
Historical ComparisonAbout DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.